| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | yes | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0043226 | organelle | 2 | 6 |
| GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4HII1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 6 |
| GO:0005488 | binding | 1 | 6 |
| GO:0005524 | ATP binding | 5 | 6 |
| GO:0017076 | purine nucleotide binding | 4 | 6 |
| GO:0030554 | adenyl nucleotide binding | 5 | 6 |
| GO:0032553 | ribonucleotide binding | 3 | 6 |
| GO:0032555 | purine ribonucleotide binding | 4 | 6 |
| GO:0032559 | adenyl ribonucleotide binding | 5 | 6 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 6 |
| GO:0036094 | small molecule binding | 2 | 6 |
| GO:0043167 | ion binding | 2 | 6 |
| GO:0043168 | anion binding | 3 | 6 |
| GO:0044183 | protein folding chaperone | 1 | 6 |
| GO:0097159 | organic cyclic compound binding | 2 | 6 |
| GO:0097367 | carbohydrate derivative binding | 2 | 6 |
| GO:0140657 | ATP-dependent activity | 1 | 6 |
| GO:0140662 | ATP-dependent protein folding chaperone | 2 | 6 |
| GO:1901265 | nucleoside phosphate binding | 3 | 6 |
| GO:1901363 | heterocyclic compound binding | 2 | 6 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.528 |
| CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.320 |
| CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.528 |
| CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.339 |
| CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.299 |
| CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.321 |
| CLV_PCSK_PC1ET2_1 | 79 | 81 | PF00082 | 0.339 |
| CLV_PCSK_PC1ET2_1 | 94 | 96 | PF00082 | 0.299 |
| CLV_PCSK_PC7_1 | 95 | 101 | PF00082 | 0.297 |
| CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.326 |
| CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.299 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.587 |
| DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.546 |
| DOC_USP7_UBL2_3 | 68 | 72 | PF12436 | 0.364 |
| DOC_WW_Pin1_4 | 133 | 138 | PF00397 | 0.378 |
| DOC_WW_Pin1_4 | 58 | 63 | PF00397 | 0.336 |
| LIG_BRCT_BRCA1_1 | 54 | 58 | PF00533 | 0.363 |
| LIG_EH1_1 | 90 | 98 | PF00400 | 0.350 |
| LIG_eIF4E_1 | 91 | 97 | PF01652 | 0.326 |
| LIG_FHA_1 | 24 | 30 | PF00498 | 0.515 |
| LIG_FHA_1 | 59 | 65 | PF00498 | 0.350 |
| LIG_LIR_Gen_1 | 36 | 44 | PF02991 | 0.378 |
| LIG_LIR_Nem_3 | 36 | 41 | PF02991 | 0.392 |
| LIG_LIR_Nem_3 | 88 | 93 | PF02991 | 0.350 |
| LIG_LRP6_Inhibitor_1 | 186 | 192 | PF00058 | 0.350 |
| LIG_PTB_Apo_2 | 109 | 116 | PF02174 | 0.350 |
| LIG_PTB_Phospho_1 | 109 | 115 | PF10480 | 0.350 |
| LIG_SH2_CRK | 115 | 119 | PF00017 | 0.350 |
| LIG_SH2_CRK | 38 | 42 | PF00017 | 0.378 |
| LIG_SH2_GRB2like | 170 | 173 | PF00017 | 0.378 |
| LIG_SH2_NCK_1 | 38 | 42 | PF00017 | 0.378 |
| LIG_SH2_STAP1 | 38 | 42 | PF00017 | 0.350 |
| LIG_SH2_STAT5 | 170 | 173 | PF00017 | 0.303 |
| LIG_SH3_3 | 162 | 168 | PF00018 | 0.321 |
| LIG_SH3_3 | 191 | 197 | PF00018 | 0.416 |
| LIG_TYR_ITIM | 113 | 118 | PF00017 | 0.350 |
| LIG_TYR_ITSM | 34 | 41 | PF00017 | 0.378 |
| MOD_Cter_Amidation | 97 | 100 | PF01082 | 0.331 |
| MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.526 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.524 |
| MOD_GSK3_1 | 36 | 43 | PF00069 | 0.326 |
| MOD_GSK3_1 | 81 | 88 | PF00069 | 0.302 |
| MOD_NEK2_1 | 148 | 153 | PF00069 | 0.483 |
| MOD_NEK2_1 | 156 | 161 | PF00069 | 0.277 |
| MOD_NEK2_1 | 34 | 39 | PF00069 | 0.324 |
| MOD_NEK2_2 | 86 | 91 | PF00069 | 0.338 |
| MOD_PIKK_1 | 135 | 141 | PF00454 | 0.388 |
| MOD_PIKK_1 | 19 | 25 | PF00454 | 0.539 |
| MOD_Plk_4 | 60 | 66 | PF00069 | 0.331 |
| MOD_Plk_4 | 86 | 92 | PF00069 | 0.378 |
| MOD_ProDKin_1 | 133 | 139 | PF00069 | 0.378 |
| MOD_ProDKin_1 | 58 | 64 | PF00069 | 0.336 |
| MOD_SUMO_rev_2 | 103 | 113 | PF00179 | 0.350 |
| TRG_DiLeu_BaLyEn_6 | 92 | 97 | PF01217 | 0.321 |
| TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.350 |
| TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.378 |
| TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.581 |
| TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.297 |
| TRG_ER_diLys_1 | 208 | 212 | PF00400 | 0.256 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0S4KFF1 | Bodo saltans | 33% | 90% |
| A4HGY0 | Leishmania braziliensis | 54% | 100% |
| A4HII6 | Leishmania braziliensis | 100% | 100% |
| C9ZR49 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 85% | 95% |